Skip to main content
Log in

Chemotherapy for larval echinococcosis in animals and humans: Report of a workshop

  • Review Article
  • Published:
Zeitschrift für Parasitenkunde Aims and scope Submit manuscript

Abstract

Mebendazole, its fluorine analogue flubendazole, and other benzimidazole derivatives are active against many gastrointestinal and tissue-stage helminths. This article reviews the published literature and proceedings of a workshop on the use of benzimidazoles against larval echinococcosis (hydatid disease). Orally administered high doses (30–50 mg/kg body weight) of mebendazole given daily for 20–90 days to rodents or sheep infected with larvalEchinococcus granulosus cause damage or destruction of the cyst wall, loss of cyst fluid, and death of protoscolices. Similar treatment of rodents infected withE. multilocularis with mebendazole, flubendazole, fenbendazole, and albendazole for 60–300 days leads to reduction of weight, inhibition of growth and of metastases formation ofE. multilocularis tissue, and to prolonged host survival time although the metacestodes are not killed. Mebendazole or flubendazole treatment of human patients infected withE. granulosus is followed by subjective improvement in most, and evidence of regression of cysts in some; in other patients, cysts continue to grow or have been proven viable even after several months of high-dose mebendazole therapy. In patients infected withE. multilocularis, the progressive course of the disease appeared to be arrested, but treatment apparently did not kill the parasite. Side effects in some patients have included allergic reactions, alopecia, and reversible neutropenia. Some possible reasons for differnet responses to treatment include inadequate plasma drug absorption from the gut and age, condition, and location of cysts. Many remaining questions concerning the risk versus benefits of mebendazole therapy can be answered only through controlled clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abboud Al Janabi T (1980) Surgical finding in hydatidosis after mebendazole therapy. Abstr. Tenth Internat Congr Trop Med Malaria, Manila, November 9–15, 178

  2. Akovbiantz A, Eckert J, Hess U, Schmid M (1977) Clinical experience with mebendazole treatment of human echinococcosis. Proc XIth Internat Cong Hydatidosis, Athens, Greece, May 30–June 2

  3. Al-Moslih MI, Al-Rawas AY, Rassam S, Al-Dabagh MA, Al-Janari TA, Shafik MA, Al-Ani MS (1978) Treatment of hydatidosis. Brit Med J 2: 1435

    Google Scholar 

  4. Allan RJ, Goodman HT, Watson TR (1980) Two high performance liquid chromatographic determinations for mebendazole and its metabolites in human plasma using a rapid Sep Pak C18 extraction. J Chromatogr Biomed Appl 183:311–319

    Google Scholar 

  5. Alton KB, Patrick JE, McGuire JL (1979) High performance liquid chromatographic assay for the anthelmintic agent mebendazole in human plasma. J Pharm Sci 68:880–882

    Google Scholar 

  6. Ammann R, Akovbiantz A, Eckert J (1979) Chemotherapie der Echinokokkose des Menschen mit Mebendazol (Vermox). Schweiz Med Wschr 109:148–151

    Google Scholar 

  7. Amir-Jahed AK, Fardin R, Farzad A, Bakshandeh K (1975) Clinical echinococcosis. Ann Surg 182:541–546

    Google Scholar 

  8. Anon (1972) Janssen Pharmaceutica, Synopsis mebendazole, 3rd edit, Beerse, Belgium

  9. Barandun G (1978) Untersuchungen zur Chemotherapie der alveolären Echinokokkose und derMesocestoides corti-Infektion bei Labortieren. Vet Diss Zürich

  10. Beard TC, Rickard MD, Goodman HT (1978) Medical treatment for hydatids. Med J Aust 1:633–635

    Google Scholar 

  11. Bekhti A, Nizet M, Capron M, Dessaint JP, Santoro F, Capron A (1980) Chemotherapy of human hydatid disease with mebendazole: Follow-up of 16 cases. Acta Gastroent Belgica 43:48–65

    Google Scholar 

  12. Bekhti A, Nizet M, Magotteaux P, Dessaint JP, Capron A (1980) Experience with mebendazole therapy in human hydatid disease in Belgium, Workshop-paper, Beerse

  13. Bekhti A, Schaaps JP, Capron M, Dessaint JP, Santoro F, Capron A (1977) Treatment of hepatic hydatid disease with mebendazole: preliminary results in 4 cases. Brit Med J 2:1047–1051

    Google Scholar 

  14. Bennett EM, Behm C, Bryant C (1978) Effects of mebendazole and levamisole on tetrathyridia ofMesocestoides corti in the mouse. Int J Parasitol 8:463–466

    Google Scholar 

  15. Bircher J, Burkhardt B, Witassek F, Eckert J (1980) Experimental therapy ofEchinococcus multilocularis with mebendazole. Plasma concentration — effect relationships. Workshop-paper, Beerse

  16. Borgers M, DeNollin S, Verheyen A, Vanparijs O, Thienpont D (1975) Morphological changes in cysticerci ofTaenia taeniaeformis after mebendazole treatment. J Parasitol 61:830–843

    Google Scholar 

  17. Braithwaite PA (1981) Long-term high dose mebendazole for cystic hydatid disease of liver: failure in 2 cases. Aust New Zeal J Surg 51:23–27

    Google Scholar 

  18. Braithwaite PA, Roberts MS, Allan JR, Watson TR (1982) Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease. Eur J Clin Pharm (in press)

  19. Braithwaite PA (1980) Clinical results obtained in the treatment of hydatid disease with mebendazole in Tasmania. Workshop-paper, Beerse

  20. Brugmans JP (1979) Safety evaluation of high dosages in normal volunteers. Janssen Pharmaceutica Rep Rep 1.23, 12/03770, Beerse, Belgium

  21. Brugmans JP, Thienpont DC, Van Wijngaarden I, Vanparijs OF, Schuermans VL, Lauwers HL (1971) Mebendazole in enterobiasis: radiochemical and pilot clinical study in 1,278 subjects. J Amer Med Ass 217:313–316

    Google Scholar 

  22. Bryceson ADM, Cowie AGA, MacLeod C, White S, Edwards DA, Smyth JD, McManus DP (1980) Experience with mebendazole in the treatment of inoperable human hydatid disease in England. Workshop-paper, Beerse

  23. Bryceson ADM, Woestenborghs R, Michiels M, Van den Bossche H (1980) Bioavailability of mebendazole in man — Correlation with therapy. Workshop-paper, Beerse

  24. Burkhardt B (1981) Beiträge zur experimentellen Chemotherapie der larvalen Echinokokkose mit Untersuchungen zur biologischen Verfügbarkeit von Mebendazol bei Nagetieren. Vet Diss Zürich

  25. Campbell WC, Blair LS (1974) Treatment of the cystic stage ofTaenia crassiceps andEchinococcus multilocularis in laboratory animals. J Parasitol 60:1053–1054

    Google Scholar 

  26. Campbell WC, McCracken RO, Blair LS (1975) Effect of parenterally injected benzimidazole compounds onEchinococcus multilocularis andTaenia crassiceps metacestodes in laboratory animals. J Parasitol 61:844–852

    Google Scholar 

  27. Capron A, Capron M, Dessaint JP, Bekhti A (1980) The immunological diagnosis of hydatidosis. Its value for the evaluation of therapy of hydatid disease. A commentary. Workshop-paper, Beerse

  28. Danis M, Brücker G, Gentilini M, Richard-Lenoble D, Smith M (1977) Treatment of hepatic hydatid disease. Brit Med J 2:1356

    Google Scholar 

  29. de Boer HHM, Meuwissen JHE (1980) Experiences with high dose mebendazole treatment in echinococcosis in the Netherlands. Workshop-paper, Beerse

  30. Demoen P, Van Aelst C, Loomans J, Verhaegen H, De Cree J, Verbruggen F, Ringoir S (1973) The absorption and urinary excretion of mebendazole after oral administration. Janssen Pharmaceutica Clin Res Rep R 17635/36, September, Beerse, Belgium

  31. Eckert J (1980) Experimental chemotherapy of larval echinococcosis in laboratory animals. Workshop-paper, Beerse

  32. Eckert J, Barandun G, Pohlenz J (1978) Chemotherapie der larvalen Echinokokkose bei Labortieren. Schweiz Med Wschr 108:1104–1112

    Google Scholar 

  33. Eckert J, Burkhardt B (1980) Chemotherapy of experimental echinococcosis. Acta Trop 37:297–300

    Google Scholar 

  34. Eckert J, Pohlenz J (1976) Zur Wirkung von Mebendazol auf Metazestoden vonMesocestoides corti undEchinococcus multilocularis. Tropenmed Parasitol 27:247–262

    Google Scholar 

  35. Eckert J, Pohlenz J (1981) Efficacy of flubendazole against metacestodes ofEchinococcus granulosus inMeriones. (in preparation)

  36. French CM (1979) Cited in Anon: Studies on the epidemiology and treatment of hydatid disease in the Turkana District of Kenya. Third Annual Progress Report, African Medical and Research Foundation, Nairobi, Appendix D.

  37. French CM (1980) Experience with mebendazole therapy of hydatid disease in the Turkana District, Kenya. Workshop-paper, Beerse

  38. Gamble WG, Segal M, Schantz PM, Rausch RL (1979) Alveolar hydatid disease in Minnesota: First human case acquired in the contiguous United States. J Amer Med Ass 241:904–907

    Google Scholar 

  39. Gemmell MA, Parmeter SN, Sutton RJ, Khan N (1981) Effect of mebendazole againstEchinococcus granulosus undTaenia hydatigena cysts in naturally infected sheep and relevance to larval tapeworm infections in man. Z Parasitenkd 64:135–147

    Google Scholar 

  40. Gilevich IS, Ataev BA, Vafin AZ, Gilevich MI, Kardarov VZ (1980) (Relapses in echinococcosis disease) (Russ.) Vestnik Khirugie 124:39–45

    Google Scholar 

  41. Heath DD, Chevis RA (1974) Mebendazole and hydatid cysts. Lancet 2:218–219

    Google Scholar 

  42. Heath DD, Christie MJ, Chevis RAF (1975) The lethal effect of mebendazole on secondaryEchinococcus granulosus, cysticerci ofTaenia pisiformis and tetrathyridia ofMesocestoides corti. Parasitology 70:273–285

    Google Scholar 

  43. Heath DD, Lawrence SB (1978) The effect of mebendazole and praziquantel on the cysts ofEchinococcus granulosus, Taenia hydatigena, andT. ovis in sheep. New Zealand Vet J 26:11–15

    Google Scholar 

  44. Heykants J, Geuens I, Scheygrond H, Van den Bossche H (1979) Dose-dependance and influence of a meal on the absorption and plasma levels of flubendazole in volunteers. Janssen Pharmaceutica Clin Res Rep R 17889/18, June, Beerse, Belgium

  45. Kammerer WS (1978) Human pulmonary hydatid disease (Echinococcus granulosus) treated with mebendazole. Paper presented at Amer Soc Trop Med Hyg Meeting, November, Chicago

  46. Kammerer WS, Judge DM (1976) Chemotherapy of hydatid disease (Echinococcus granulosus) in mice with mebendazole and bithionol. Amer J Trop Med Hyg 25:714–717

    Google Scholar 

  47. Kammerer WS, Miller KEchinococcus granulosus: Permeability of hydatid cysts to mebendazole in mice. Int J Parasitol (in press)

  48. Kammerer WS, Perez-Esandi MV, Quim L (1973) The current status of the chemotherapy of hydatid disease. Bull Pan Am Health Organ 7:47–52

    Google Scholar 

  49. Kammerer WS, Schantz PM (1980) Treatment of human hydatid disease (Echinococcus granulosus) with a high-dose mebendazole regimen in the United States. Workshop-paper, Beerse

  50. Karlaganis G, Münst GJ, Bircher J (1979) High-pressure liquid-chromatographic determination of the anthelmintic drug mebendazole in plasma. J High Resol Chromatogr Comm 2:141–144

    Google Scholar 

  51. Kasai Y, Koshino I, Kawanishi N, Sakamoto H, Sasaki E, Kumagai M (1980) Alveolar echinococcosis of the liver. Ann Surg 191:145–152

    Google Scholar 

  52. Kern P, Dietrich M, Volkmer KJ (1979) Chemotherapy of echinococcosis with mebendazole: Clinical observations of 7 patients. Tropenmed Parasitol 30:65–72

    Google Scholar 

  53. Kern P (1980) Human echinococcosis: follow-up of 23 patients treated with mebendazole. Workshop-paper, Beerse

  54. Keystone JS, Murdoch JK (1979) Mebendazole: Diagnostic and treatment — drugs five years later. Ann Intern Med 91:582–586

    Google Scholar 

  55. Kovalenko FP, Krotov AI, Budanova IS, Razako SHA (1976) (Experimental therapy of echinococcosis. Part 1. Laboratory model of echinococcosis and influence exerted by sarcolysinacridine, levamisole, and mebendazole on the development ofEchinococcus granulosus larvocysts.) (Russ.) Med Parazitol 45:546–551

    Google Scholar 

  56. Krotov AI, Chernyaeva AI, Budanova IS (1976) (Experimental therapy of alveococcosis. Part 3. Influence of thiabendazole, sarcolysinacridine, levamisole, and mebendazole on the development ofAlveococcus larvocysts in albino mice.) (Russ.) Med Parazitol 45:164–168

    Google Scholar 

  57. Krotov AI, Chernyaeva AI, Kovalenko FP, Bayandina DG, Budanova IS, Kuznetsova OE, Voskoboinik LV (1974) (Experimental therapy of alveococcosis. II. Effectiveness of some antinematode agents against alveococcosis of laboratory animals) (Russ.) Med Parazitol 43:314–321

    Google Scholar 

  58. Krotov AI, Tret'yakov SA, Dzhabarova VI, Chernyaeva AI (1977) (Experimental therapy of alveococcosis. Part V. Effectiveness of mebendazole in experimental animals with various modes of administration.) (Russ.) Med Parazitol 46:480–484

    Google Scholar 

  59. Little JM (1976) Hydatid disease at Royal Prince Alfred Hospital, 1964 to 1974. Med J Aust 1:903–908

    Google Scholar 

  60. Löscher T, Sonnenburg FV, Lang W (1980) Control of mebendazole-therapy in echinococcosis. Abstr Tenth Internat Congr Trop Med Malaria, Manila, November 9–15, 176–177

  61. Lüdin CE, Gyr K, Karoussos K (1977) Therapy of alveococcosis in man. J Int Med Res 5:367–368

    Google Scholar 

  62. Markell EK (1975) Mebendazole in hydatid disease. Lancet 1:925

    Google Scholar 

  63. Marsboom R (1973) Toxicologic studies on mebendazole. Toxicol Appl Pharm 24:371–377

    Google Scholar 

  64. Matossian RM, Rickard MD, Smyth JD (1977) Hydatidosis: a global problem of increasing importance. Bull WHO 55:499–507

    Google Scholar 

  65. Michiels M, Hendriks R, Thijssen J, Heykants J (1978) A sensitive radioimmunoassay for mebendazole (R17635) and flubendazole (R17889). Janssen Pharmaceutica Preclinical Res Rep R17635/11 and R17889/9, November, Beerse, Belgium

  66. Michiels M, Hendriks R, Heykants J, Van denBossche H (1980) The pharmacokinetics of mebendazole and flubendazole in animals and man. Workshop-paper, Beerse

  67. Michiels M, Heykants J, Van den Bossche H, Verhoeven H (1980) A comparative study on the systemic absorption of oral and subcantaneous mebendazole, flubendazole and R 34803 in two different rodents. Janssen Research Products Information Service No. R 17635/13, R 17889/12, R 34803/5

  68. Miskovitz PF, Javitt NB (1980) Leukopenia associated with mebendazole therapy of hydatid disease. Amer J Trop Med Hyg 29:1356–1358

    Google Scholar 

  69. Mosimann F (1980) Is alveolar hydatid disease of the liver incurable? Ann Surg 192:118–123

    Google Scholar 

  70. Mottaghian H, Saidi F (1978) Postoperative recurrence of hydatid disease. J Surg 65:237–242

    Google Scholar 

  71. Müller E, Akovbiantz A, Ammann RW, Bircher J, Eckert J, Wissler K, Witassek F, Wüthrich B. Treatment of human echinococcosis with mebendazole. Preliminary observations on 28 patients. (in preparation)

  72. Münst GJ, Karlaganis G, Bircher J (1980) Plasma concentrations of mebendazole during treatment of echinococcosis. Preliminary results. Eur J Clin Pharm 17:375–378

    Google Scholar 

  73. Murray-Lyon IM, Reynolds KW (1979) Complication of mebendazole treatment for hydatid disease. Brit Med J 2:1111–1112

    Google Scholar 

  74. Nassar NT, Salameh VS, Ghassan KR (1980) Clinical results with low and high dose mebendazole treatment of hydatid disease in Lebanon. Workshop-paper, Beerse

  75. Nizet M, Bekhti A, Magotteaux P (1980) Survey of the therapy of hydatid disease by ultrasound and by computerized tomography. Workshop-paper, Beerse

  76. Nolla Panades R, Nolla Salas M, Alvarez Lerma F, Torres Rodriguez JM (1980) Tratamiento de la hidatidosis microvesicular con mebendazol. Rev Clin Esp 156:295–303

    Google Scholar 

  77. Pawlowski Z, Kozakiewicz B, Zatonski J (1976) Effect of mebendazole on hydatid cysts in pigs. Vet Parasitol 2:299–302

    Google Scholar 

  78. Pinch LW, Wilson JF (1975) Nonsurgical management of cystic hydatid disease in Alaska: a review of 30 cases ofEchinococcus granulosus infection treated without operation. Ann Surg 178:45–48

    Google Scholar 

  79. Quilici M, Dumon H, Delmont J (1976) Les modalités de constitution des (recidives) postoperatoires de l'échinococcose àEchinococcus granulosus. Médecine Maladies Infect 6:12–16

    Google Scholar 

  80. Quilici M, Dumon H, Rampal M, Alimi JC (1979) Hydatidose: traitement préoperatoire par fluoromebendazole. Nouv Presse Méd 8:524

    Google Scholar 

  81. Rassam S (1980) Medical treatment of hydatid disease in Iraq. Abstr. Tenth Internat Congr Trop Med Malaria, Manila, November 9–15, 178–179

  82. Reisin IL, Benitez AJ, Ibarra CA (1980) Experience with mebendazole therapy of hydatid disease in Argentina. Workshop-paper, Beerse

  83. Reisin IL, Pavisic de Fala CI, Cantiello H, Ibarra CA (1980) Effect of mebendazole on carbohydrate and electrolyte transport across the membranes of larvalEchinococcus granulosus. Workshop-paper, Beerse

  84. Reisin IL, Rabito CA, Rotunno CA, Cereijido M (1977) The permeability of the membranes of experimental secondary cysts ofEchinococcus granulosus to C14 mebendazole. Int J Parasitol 7:189–194

    Google Scholar 

  85. Schantz PM, Kagan IG (1980) Echinococcosis (hydatidosis). In: Houba V (ed) Immunological Investigation of Tropical Parasitic Disease. Churchill Livingstone, Edinburgh p. 104–129

    Google Scholar 

  86. Schiller CT (1966) Complications of echinococcus cyst rupture: a study of 3 cases. J Amer Med Ass 195:220–222

    Google Scholar 

  87. Semenov VS, Pechen OR, Papovodu P (1954) Alveolianogo ekkinokokka. Vestnik Khirurgia Grekov 74:20

    Google Scholar 

  88. Smyth JD, Barrett NJ (1980) Procedures for testing the viability of human hydatid cysts following surgical removal, especially after chemotherapy. Trans Roy Soc Trop Med Hyg 74:649–652

    Google Scholar 

  89. Starke J (1979) Konservative Therapie desEchinococcus alveolaris der Leber. Vorläufige Mitteilung. Dtsch Med Wschr 104:1132–1135

    Google Scholar 

  90. Thienpont D, Vanparijs OFJ, Hermans LC (1973) Mebendazole, a new potent drug againstSyngamus trachea in turkeys. Poultry Sci 52:1712–1714

    Google Scholar 

  91. Thienpont D, Vanparijs O, Hermans L (1974) Anthelmintic activity of mebendazole againstCysticercus fasciolaris. J Parasitol 60:1052–1053

    Google Scholar 

  92. Thienpont D, Vanparijs OFJ, Vandersteene R (1974) Anthelmintic and histopathological effects of mebendazole onTrichinella spiralis in the rat. In: Kim CHW (ed) Trichinellosis. Educational Publishers, New York, p. 515–527

    Google Scholar 

  93. Thienpont D, Vanparijs O, Hermans L (1979) Prophylactic activity of mebendazole and flubendazole on secondary echinococcosis byEchinococcus granulosus in mice. Janssen Pharmaceutica Clin Res Rep No. R17635 and R17889, May, Beerse, Belgium

  94. Thienpont D (1980) Experimental chemotherapy of larval echinococcosis in domestic animals. A review. Workshop-paper, Beerse

  95. Tinar R (1979) (Effect of new anthelmintics on hydatid cysts in experimentally infected sheep.) Ankara University Veteriner Fakült Derg 26:145–168

    Google Scholar 

  96. Van den Bossche H (1976) The molecular basis of anthelmintic action. In: Van den Bossche H (ed) Biochemistry of Parasites and Host-Parasite Relationship. Elsevier-North Holland Publ Comp, New York, p 553–572

    Google Scholar 

  97. Van den Bossche H (1980) Peculiar targets in anthelmintic chemotherapy. Biochem Pharm 29:1981–1990

    Google Scholar 

  98. Van den Bossche H, Janssen PAJ (1981) Mode of action of known and experimental antifilarial compounds. Proc Sympos Chemotherapy and Immunology in the Control of Malaria, Filariatis and Leishmaniasis. February 17–21, Lucknow, India (in press)

  99. Van den Bossche H, Thienpont D (1980) Anthelmintica. In: Lammers W, Nelemans FA, Bouwman THJ, Van Noordwijk J, Offerhaus L, Rosinga WM, Vermeulen A (eds) Algemene Farmacotherapie. Het geneesmiddel in theorie in praktijk, Stafleu, Alphen, The Netherlands p 752–793

  100. Vanparijs O, Hermans L, Thienpont D (1976) Anthelmintic activity of mebendazole on larval stages ofEchinococcus granulosus in mice. Janssen Pharmaceutica Biol Res Rep R17635, May, Beerse, Belgium

  101. Van Wijngaarden I (1971) Excretion and metabolism of C14-labelled mebendazole in rats and men. Janssen pharmaceutica Biol Res Rep R17635/2, January, Beerse, Belgium

  102. Verheyen A (1982)Echinococcus granulosus: The influence of mebendazole therapy on the ultrastructural morphology of the germinal layer of hydatid cysts in man and in mice. Z Parasitenkd (in press)

  103. Verheyen A, Vanparijs O, Borgers M, Thienpont D (1978) Scanning electron microscopic observations ofCysticercus fasciolaris (=Taenia taeniaeformis) after treatment of mice with mebendazole. J Parasitol 64:411–425

    Google Scholar 

  104. Werczberger A, Golhman J, Werthein G, Gunders AE, Chowers J (1979) Disseminated echinococcosis with repeated anaphylactic shock treated with mebendazole. Chest 76:482–484

    Google Scholar 

  105. Williams JF, Lopez Adaros H, Trejos A (1971) Current prevalence and distribution of hydatidosis with special reference to the Americas. Amer J Trop Med Hyg 20:224–236

    Google Scholar 

  106. Wilson JF, Davidson M, Rausch RL (1978) A clinical trial of mebendazole in the treatment of alveolar hydatid disease. Am Rev Respir Dis 118:747–757

    Google Scholar 

  107. Wilson JF, Rausch RL (1980) Alveolar hydatid disease. A review of clinical features of 33 indigenous cases ofEchinococcus multilocularis infection in Alaskan Eskimos. Amer J Trop Med Hyg 29:1340–1355

    Google Scholar 

  108. Wilson JF, Rausch RL (1980) Long term mebendazole therapy of alveolar hydatid disease in Alaskan Eskimos. Workshop-paper, Beerse

  109. Witassek F, Burkhardt B, Eckert J, Bircher J (1981) Chemotherapy of alveolar echinococcosis. Comparison of plasma mebendazole concentrations in animals and man. Eur J Clin Pharm 20:427–433

    Google Scholar 

  110. Wynants J, Hendrickx J, Heykants J (1975) A high performance liquid chromatographic among method for mebendazole in plasma and tissues in the 0.1–0.01 ppm range. Janssen Pharmaceutica Biol Res Rep R17635/6, January, Beerse, Belgium

  111. Zhongxi Q, Shuyuan G, Guozue T, Ruilin L, Mingbai W, Jun Q, Kurban (1980) Immediate and long-term results of surgical treatment of intrathoracic hydatid cysts. Chin Med J 93:569–572

    Google Scholar 

  112. Zhongxi Q, Shuyuan G, Guoxue T, Ruilin L, Mingbai W, Jun Q, Kurban (1980) Evaluation of Barrett's technique in 167 cases of pulmonary hydatid cyst. Chin Med J 93:577–580

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Organized by the Janssen Research Foundation at Janssen Pharmaceutica, Beerse Belgium, November 24–25, 1980. Contributors: R.W. Ammann, A. Bartlett, A. Bekhti, J. Bircher, P.A. Braithwaite, A. Bryceson A. Capron, H. De Boer, J. Eckert, M. French, W.S. Kammerer, P. Kern, R. Marsboom, M. Michiels, N. Nassar, M. Nizet, I.L. Reisin, A. Sabrie, P.M. Schantz, J.D. Smyth, D. Thienpont, H. Van den Bossche, A. Verheyen, J.F. Wilson

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schantz, P.M., Van den Bossche, H. & Eckert, J. Chemotherapy for larval echinococcosis in animals and humans: Report of a workshop. Z. Parasitenkd. 67, 5–26 (1982). https://doi.org/10.1007/BF00929509

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00929509

Keywords

Navigation